doi: 10.3389/fendo.2026.1858420 Received 17 April 2026 Revised 19 June 2026 Accepted 19 June 2026 Published 06 July 2026 Volume 17 - 2026 Edited by Srinivas Mummidi, Texas A&M University San Antonio, United States Reviewed by Raylene A
E., Grober, E., Ohl, D., & Kim, E
Retatrutide A Game Changer in Obesity Pharmacotherapy (Biomolecules)
Proper storage is not optional, it is a fundamental part of accurate dosing because a degraded peptide at the correct volume still delivers less than the intended dose
For IGF-1 LR3, the primary method is subcutaneous (SubQ) injection
Like all potent biological compounds, IGF-1 LR3 should be approached carefully